Login / Signup
Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment.
Navid Manouchehri
Olaf Stüve
Published in:
Therapeutic advances in neurological disorders (2021)
Keyphrases
</>
multiple sclerosis
white matter